E ISSN: 2583-049X
logo

International Journal of Advanced Multidisciplinary Research and Studies

Volume 5, Issue 4, 2025

A positive effect of galcanezumab in MELAS must be proven by appropriately designed studies



Author(s): Josef Finsterer

DOI: https://doi.org/10.62225/2583049X.2025.5.4.4632

Abstract:

None.


Keywords: Migraine, MELAs, CADASIL, Erenumab, Galcanezumab

Pages: 485-486

Download Full Article: Click Here